X4 Pharmaceuticals (XFOR) Earnings
|
Expand Research on XFOR
| Next EPS Date | N/A | EPS Growth Rate | -283.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +25.6% | Revenue Growth Rate | +214.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/5/25 | Q325 | -$0.69 | $0.00 | -$0.69 | $1.76M | N/A | N/A |  | | Details | |
7/31/25  |
Q225 | N/A | -$0.09 | N/A | N/A | $2.93M | N/A | N/A | N/A | ||
| 5/1/25 | Q125 | $0.04 | -$0.12 | +$0.16 | $28.81M | $12.03M | N/A | | | Details | |
| 3/25/25 | Q424 | -$0.20 | -$0.16 | -$0.04 | $1.43M | $990.71K | N/A | | | Details | |
| 3/13/25 |
Q424 | N/A | -$0.16 | N/A | N/A | $990.71K | N/A | N/A | N/A | ||
| 11/13/24 | Q324 | -$0.18 | -$0.17 | -$0.01 | $560K | $1.69M | N/A | | | Details | |
| 8/8/24 | Q224 | $0.45 | -$0.01 | +$0.46 | $260K | $15.27M | N/A | | | Details | |
| 8/1/24 | Q224 | N/A | -$0.01 | N/A | N/A | $15.27M | N/A | N/A | N/A |
